Personalis Other Non-Current Liabilities 2018-2025 | PSNL
Personalis other non-current liabilities from 2018 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Personalis Annual Other Non-Current Liabilities
(Millions of US $) |
| 2024 |
$1 |
| 2023 |
$10 |
| 2022 |
$0 |
| 2021 |
$2 |
| 2020 |
$1 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
Personalis Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2025-03-31 |
$2 |
| 2024-12-31 |
$1 |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$3 |
| 2024-03-31 |
$6 |
| 2023-12-31 |
$10 |
| 2023-09-30 |
$4 |
| 2023-06-30 |
$4 |
| 2023-03-31 |
$4 |
| 2022-12-31 |
$0 |
| 2022-09-30 |
$0 |
| 2022-06-30 |
$0 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
|
| 2019-09-30 |
$1 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.447B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
